HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

William R Prucka Selected Research

tanezumab

1/2020Onset and maintenance of efficacy of subcutaneous tanezumab in patients with moderate to severe osteoarthritis of the knee or hip: A 16-week dose-titration study.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


William R Prucka Research Topics

Disease

3Pain (Aches)
01/2020 - 05/2014
2Osteoarthritis
01/2020 - 06/2014
2Chronic Pain
06/2014 - 05/2014
1Knee Osteoarthritis
01/2020
1Arthralgia (Joint Pain)
01/2020
1Dizziness (Lightheadedness)
06/2014
1Nausea
06/2014
1Neuralgia (Stump Neuralgia)
06/2014
1Vomiting
06/2014
1Hyperalgesia
05/2014
1Schizophrenia (Dementia Praecox)
01/2010

Drug/Important Bio-Agent (IBA)

2dasolampanel etibutilIBA
06/2014 - 05/2014
2Ionotropic Glutamate ReceptorsIBA
06/2014 - 05/2014
1tanezumabIBA
01/2020
1Analgesics (Analgesic Drugs)IBA
05/2014
1Gabapentin (Neurontin)FDA LinkGeneric
05/2014
1Antidepressive Agents (Antidepressants)IBA
01/2010
1Pharmaceutical PreparationsIBA
01/2010